Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in imatinib-resistant/intolerant GIST
NCT00075218Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2003
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of sunitinib in gastrointestinal stromal tumor (GIST), sponsored by Pfizer. Started Dec 2003; status: completed.
02
Drugs
sunitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00075218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075218.